1. ©2019 Transparency Market Research, All Rights Reserved The global active pharmaceutical ingredients (API) market is expanding due to an increase in the incidence of acute and chronic disease such as cancer across the globe. The global active pharmaceutical ingredients (API) market was valued at US$ 162,000.0 Mn in 2017. It is projected to reach a value of US$ 257,455.6 by 2026 and expand at a CAGR of 5.4% from 2018 to 2026. Active Pharmaceutical Ingredients (API) Market ©2019 Transparency Market Research, All Rights Reserved

2. ©2019 Transparency Market Research, All Rights Reserved Active Pharmaceutical Ingredients (API) Market - Overview  Biotech/biological evolution, owing to a shift from synthetic chemical APIs to biotech/biological APIs in the global active pharmaceutical ingredients market.  Rise in demand for new drugs at a low cost and entry of domestic and global companies in the APIs market have led to innovative product offerings with new and advanced techniques. Any substance or combination of substances used in a finished pharmaceutical product (FPP) is known as active pharmaceutical ingredients (API). A finished dose of any drug is a combination of active pharmaceutical ingredients and excipients. An excipient is an inactive substance in a drug dose.  The global active pharmaceutical ingredients market has been broadly segmented based on manufacturer, APIs, drug, therapeutic, and region. In terms of manufacturer, the global market has been classified into in- house API manufacturing and API contract manufacturing. The in-house API manufacturing segment accounted for a key share of the global market, in terms of revenue, in 2017. The API contract manufacturing segment is estimated to expand at a significant growth rate during the forecast period. Consequently, the segment is estimated to gain significant market share by the end of 2026. APIs have witnessed constant technological

3. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Market Outlook Global Active Pharmaceutical Ingredients (API) Analysis and Forecasts, by Type of Manufacturers Chapter 6 Global Active Pharmaceutical Ingredients (API) Analysis and Forecasts, by Type of APIs Chapter 7 Global Active Pharmaceutical Ingredients (API) Analysis and Forecasts, by Type of Drug Chapter 8 Global Active Pharmaceutical Ingredients (API) Analysis and Forecasts, by Therapeutic Chapter 9 lobal Active Pharmaceutical Ingredients (API) Analysis and Forecasts, by Region Chapter 10

4. ©2019 Transparency Market Research, All Rights Reserved Increase in Government Prioritization of Biomedical Innovation Globally to Fuel Market Governments across the world have prioritized biomedical innovation. Accelerated regulatory review by the FDA for innovative medicines boosts the global active pharmaceutical ingredients market. The FDA has approved more than 45 drugs in 2017. Drugs approved by the FDA are used for the treatment of relapsed or refractory acute lymphoblastic leukemia, relapsed breast cancer, moderate-to-severe plaque psoriasis, advanced or metastatic urothelial carcinoma, acute bacterial skin infections, Chagas disease, open-angle glaucoma or ocular hypertension, type 2 diabetes mellitus, and septic or other distributive shock. Request Brochure of Report ©2019 Transparency Market Research, All Rights Reserved

5. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U